Similar articles

• [Results of treatment of myocardial infarction associated with shock in relation to the kind of administered drugs].

  Markiewicz M. Markiewicz M. Pol Tyg Lek. 1968 May 6;23(19):698-700. Pol Tyg Lek. 1968. PMID: 4299413 Polish. No abstract available.
• [Vasopressor drugs in shock due to myocardial infarction].

  Adamska-Dyniewska H. Adamska-Dyniewska H. Pol Tyg Lek. 1967 Oct 2;22(45):1744-7. Pol Tyg Lek. 1967. PMID: 4294154 Review. Polish. No abstract available.
• [Incidence of cardiogenic shock in patients with acute myocardial infarct. A few remarks on mortality and therapeutic possibilities].

  Klener P, Chlup J. Klener P, et al. Cas Lek Cesk. 1969 May 23;108(22):663-6. Cas Lek Cesk. 1969. PMID: 4306705 Czech. No abstract available.
• [Use of hypertensin in the treatment of shock in myocardial infarct].

  Faerchtein I, Roque AF, Maciel FS, Kastansky I. Faerchtein I, et al. Hospital (Rio J). 1965 Sep;68(3):659-68. Hospital (Rio J). 1965. PMID: 4285308 Clinical Trial. Portuguese. No abstract available.
• The physiologic basis for treatment of shock associated with myocardial infarction.

  Gunnar RM, Pietras RJ, Stavrakos C, Loeb HS, Tobin JR Jr. Gunnar RM, et al. Med Clin North Am. 1967 Jan;51(1):69-81. doi: 10.1016/s0025-7125(16)33083-8. Med Clin North Am. 1967. PMID: 4869243 Review. No abstract available.